OBJECTIVE: To assess relations among midpregnancy vaginal defensin levels, a component of the host innate immune response, bacterial vaginosis, and risk of preterm delivery. These relations are compared across race groups because previous studies have repeatedly shown that the prevalence of bacterial vaginosis and the risk of preterm delivery are greater in African-American women compared with that in white women. METHODS: Data are from a prospective study that enrolled pregnant women from 52 clinics in five Michigan communities. In the study subcohort, defensins (human neutrophil peptides 1, 2 and 3) and bacterial vaginosis (Nugent criteria) were measured in vaginal fluid collected at enrollment (15th through 27th week of pregnancy) from 1,031 non-Hispanic white and African-American women (787 term, 244 preterm). Preterm deliveries were categorized by clinical circumstances, ie, spontaneous and medically indicated. RESULTS: Among African Americans, vaginal human neutrophil peptides 1-3 levels greater than or equal to the median were associated with bacterial vaginosis and specifically with spontaneous preterm delivery only (adjusted odds ratio 2.3, 95% confidence interval 1.2-4.3). Once African-American women were stratified by human neutrophil peptide 1-3 levels, bacterial vaginosis added nothing to the prediction of spontaneous preterm delivery risk. None of the above associations were observed in non-Hispanic whites. CONCLUSION: The relations among human neutrophil peptide 1-3 levels, bacterial vaginosis, and preterm delivery vary by race group. In African Americans, midpregnancy human neutrophil peptide 1-3 levels were more informative to preterm delivery risk than was bacterial vaginosis, suggesting an important role for host response. In addition, elevated human neutrophil peptide 1-3 levels may be a marker for particular high-risk vaginal milieus that are not distinguished by the current bacterial vaginosis Nugent scoring system.
OBJECTIVE: To assess relations among midpregnancy vaginal defensin levels, a component of the host innate immune response, bacterial vaginosis, and risk of preterm delivery. These relations are compared across race groups because previous studies have repeatedly shown that the prevalence of bacterial vaginosis and the risk of preterm delivery are greater in African-American women compared with that in white women. METHODS: Data are from a prospective study that enrolled pregnant women from 52 clinics in five Michigan communities. In the study subcohort, defensins (humanneutrophil peptides 1, 2 and 3) and bacterial vaginosis (Nugent criteria) were measured in vaginal fluid collected at enrollment (15th through 27th week of pregnancy) from 1,031 non-Hispanic white and African-American women (787 term, 244 preterm). Preterm deliveries were categorized by clinical circumstances, ie, spontaneous and medically indicated. RESULTS: Among African Americans, vaginal human neutrophil peptides 1-3 levels greater than or equal to the median were associated with bacterial vaginosis and specifically with spontaneous preterm delivery only (adjusted odds ratio 2.3, 95% confidence interval 1.2-4.3). Once African-American women were stratified by humanneutrophil peptide 1-3 levels, bacterial vaginosis added nothing to the prediction of spontaneous preterm delivery risk. None of the above associations were observed in non-Hispanic whites. CONCLUSION: The relations among humanneutrophil peptide 1-3 levels, bacterial vaginosis, and preterm delivery vary by race group. In African Americans, midpregnancy humanneutrophil peptide 1-3 levels were more informative to preterm delivery risk than was bacterial vaginosis, suggesting an important role for host response. In addition, elevated humanneutrophil peptide 1-3 levels may be a marker for particular high-risk vaginal milieus that are not distinguished by the current bacterial vaginosis Nugent scoring system.
Authors: M A Klebanoff; J C Carey; J C Hauth; S L Hillier; R P Nugent; E A Thom; J M Ernest; R P Heine; R J Wapner; W Trout; A Moawad; K J Leveno; M Miodovnik; B M Sibai; J P Van Dorsten; M P Dombrowski; M J O'Sullivan; M Varner; O Langer; D McNellis; J M Roberts Journal: N Engl J Med Date: 2001-08-16 Impact factor: 91.245
Authors: Roberto Romero; Jimmy Espinoza; Luís F Gonçalves; Juan Pedro Kusanovic; Lara A Friel; Jyh Kae Nien Journal: Semin Fetal Neonatal Med Date: 2006-07-12 Impact factor: 3.926
Authors: J C Carey; M A Klebanoff; J C Hauth; S L Hillier; E A Thom; J M Ernest; R P Heine; R P Nugent; M L Fischer; K J Leveno; R Wapner; M Varner Journal: N Engl J Med Date: 2000-02-24 Impact factor: 91.245
Authors: Hyagriv N Simhan; Brenna L Anderson; Marijane A Krohn; R Phillips Heine; Begoña Martinez de Tejada; Daniel V Landers; Sharon L Hillier Journal: Am J Obstet Gynecol Date: 2007-01 Impact factor: 8.661
Authors: William W Andrews; Baha M Sibai; Elizabeth A Thom; Donald Dudley; J M Ernest; Donald McNellis; Kenneth J Leveno; Ronald Wapner; Atef Moawad; Mary J O'Sullivan; Steve N Caritis; Jay D Iams; Oded Langer; Menachem Miodovnik; Mitchell Dombrowski Journal: Obstet Gynecol Date: 2003-05 Impact factor: 7.661
Authors: Rukmini B Balu; David A Savitz; Cande V Ananth; Katherine E Hartmann; William C Miller; John M Thorp; R Phillips Heine Journal: Obstet Gynecol Date: 2003-05 Impact factor: 7.661
Authors: Jeny P Ghartey; Colleen Carpenter; Philip Gialanella; Charlotte Rising; Thomas C McAndrew; Mohak Mhatre; Jessica Tugetman; Mark H Einstein; Cynthia Chazotte; Betsy C Herold Journal: Am J Obstet Gynecol Date: 2012-07-26 Impact factor: 8.661
Authors: Caroline Mitchell; Michelle L Gottsch; Congzhou Liu; David N Fredricks; Deborah B Nelson Journal: Am J Obstet Gynecol Date: 2012-11-19 Impact factor: 8.661
Authors: Andrea Lewis; Thomas P McKeon; Anneclaire J De Roos; Jacques Ravel; Michal A Elovitz; Heather H Burris Journal: Environ Res Date: 2021-06-02 Impact factor: 8.431